Mercer Global Advisors Inc Lyell Immunopharma, Inc. Transaction History
Mercer Global Advisors Inc
- $35.2 Billion
- Q1 2024
A detailed history of Mercer Global Advisors Inc transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 42,792 shares of LYEL stock, worth $66,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,792Holding current value
$66,755% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
128Shares Held
144MCall Options Held
0Put Options Held
5.9K-
Mwg Management Ltd. Washington, DC20.2MShares$31.5 Million33.29% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$23.5 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$23.5 Million19.02% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$21.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$20.9 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $387M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...